Published in Arch Intern Med on January 24, 2000
British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax (2003) 5.83
Pulmonary embolism in hospital practice. BMJ (2006) 2.27
Splenic spontaneous rupture (SSR) and hemoperitoneum associated with low molecular weight heparin: a case report. Support Care Cancer (2003) 0.96
Development of a dosage strategy in patients receiving enoxaparin by continuous intravenous infusion using modelling and simulation. Br J Clin Pharmacol (2006) 0.88
Rivaroxaban for the treatment of pulmonary embolism. Adv Ther (2013) 0.81
Acute pulmonary embolism 2: treatment. Heart (2001) 0.81
Low molecular weight heparin-induced pharmacological modulation of burn wound healing. Ann Burns Fire Disasters (2006) 0.81
Rates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar. Thromb J (2005) 0.78
Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism. J Thromb Thrombolysis (2016) 0.77
Is there enough evidence that low-molecular-weight heparin is superior to unfractionated heparin in pulmonary embolism? Arch Intern Med (2000) 0.75
Successful thrombolysis following enoxaparin therapy in two pediatric patients with congenital heart disease presenting with intracardiac and cerebral thrombosis. Thromb J (2014) 0.75
Low-molecular-weight heparins in the treatment of venous thromboembolism. Curr Control Trials Cardiovasc Med (2000) 0.75
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell (1998) 17.76
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood (1996) 7.31
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A (1999) 5.78
Prevention of venous thromboembolism. Chest (2001) 5.59
Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med (1998) 3.70
Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med (1992) 3.23
Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med (1986) 3.00
Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review. Ann Intern Med (2000) 2.82
Chronic idiopathic thrombocytopenic purpura. N Engl J Med (1994) 2.66
Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med (1990) 2.63
Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature (1995) 2.45
Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med (2001) 2.37
Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study. J Abnorm Child Psychol (2000) 2.36
Case-control study of prenatal ultrasonography exposure in children with delayed speech. CMAJ (1993) 2.31
Cost-effectiveness of pulmonary embolism diagnosis. Arch Intern Med (1996) 2.24
Low-probability lung scan findings: a need for change. Ann Intern Med (1991) 2.22
Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr (2001) 2.20
A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol (1991) 2.08
Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study. J Thromb Haemost (2014) 2.03
Identification of the proteins of the yeast U1 small nuclear ribonucleoprotein complex by mass spectrometry. Proc Natl Acad Sci U S A (1997) 2.02
Pulmonary artery flow directed catheter: the evidence. Lancet (1996) 2.02
Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nat Biotechnol (1998) 1.99
Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism. Chest (1985) 1.92
Interaction of the U1 snRNP with nonconserved intronic sequences affects 5' splice site selection. Genes Dev (1999) 1.91
Psychosocial treatment strategies in the MTA study: rationale, methods, and critical issues in design and implementation. J Abnorm Child Psychol (2000) 1.81
The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society. Am J Respir Crit Care Med (1999) 1.80
Family processes and treatment outcome in the MTA: negative/ineffective parenting practices in relation to multimodal treatment. J Abnorm Child Psychol (2000) 1.76
Reassessment of pulmonary angiography for the diagnosis of pulmonary embolism: relation of interpreter agreement to the order of the involved pulmonary arterial branch. Radiology (1999) 1.74
Clinical validity of a normal perfusion lung scan in patients with suspected pulmonary embolism. Chest (1990) 1.65
Trichromacy, opponent colours coding and optimum colour information transmission in the retina. Proc R Soc Lond B Biol Sci (1983) 1.59
Medication treatment strategies in the MTA Study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry (1996) 1.58
Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement. JAMA (1990) 1.55
Cardiac output measurement by transpulmonary versus conventional thermodilution technique in intensive care patients after coronary artery bypass grafting. J Cardiothorac Vasc Anesth (1998) 1.54
The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence. Arch Intern Med (1997) 1.53
A prospective investigation of pulmonary embolism in women and men. JAMA (1992) 1.52
A clinical study of the relationship between silicone breast implants and connective tissue disease. J Rheumatol (1998) 1.52
Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med (1983) 1.51
The diagnosis of acute pulmonary embolism in patients with chronic obstructive pulmonary disease. Chest (1992) 1.51
Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement. Arch Intern Med (1999) 1.50
The nature and prevention of prosthetic valve endocarditis. Am Heart J (1966) 1.49
Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators. Arch Intern Med (2000) 1.48
The electrocardiogram in acute pulmonary embolism. Prog Cardiovasc Dis (1975) 1.46
Ca2+-dependent hydrophobic-interaction chromatography. Isolation of a novel Ca2+-binding protein and protein kinase C from bovine brain. Biochem J (1984) 1.45
Electrocardiographic monitoring during cardiac rehabilitation. Chest (1995) 1.45
Physician-guided treatment compared with a heparin protocol for deep vein thrombosis. Arch Intern Med (1994) 1.44
Administration of bovine polymerized haemoglobin before and during coronary occlusion reduces infarct size in rabbits. Br J Anaesth (2009) 1.43
Evaluation of individual criteria for low probability interpretation of ventilation-perfusion lung scans. J Nucl Med (1996) 1.42
The relative role of subendocardium and subepicardium in left ventricular mechanics. Am J Physiol (1981) 1.42
Withholding treatment in patients with acute pulmonary embolism who have a high risk of bleeding and negative serial noninvasive leg tests. Am J Med (2000) 1.40
Effect of the social environment on alcohol involvement and subjective well-being prior to alcoholism treatment. J Stud Alcohol (1993) 1.39
Silent pulmonary embolism. Arch Intern Med (2000) 1.39
History and physical examination in acute pulmonary embolism in patients without preexisting cardiac or pulmonary disease. Am J Cardiol (1981) 1.39
Assessment of cardiac performance with quantitative radionuclide angiocardiography: right ventricular ejection fraction with reference to findings in chronic obstructive pulmonary disease. Am J Cardiol (1978) 1.37
Fluorescent tagging of herpes simplex virus tegument protein VP13/14 in virus infection. J Virol (2001) 1.35
National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices. Arch Gen Psychiatry (1997) 1.35
The sensory somatotopic map of the human hand demonstrated at 4 Tesla. Neuroimage (1999) 1.35
Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators. Arch Intern Med (2000) 1.34
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective. Arch Intern Med (1997) 1.34
Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family. Proc Natl Acad Sci U S A (1999) 1.34
An infertile male with balanced Y;19 translocation. Review of Y;autosome translocations. Ann Genet (1979) 1.31
The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas. J Lab Clin Med (1973) 1.30
Nuclear localization and shuttling of herpes simplex virus tegument protein VP13/14. J Virol (2001) 1.30
Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin. Lancet (1992) 1.29
Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22. Gene Ther (1999) 1.29
Turbulent blood flow in humans: its primary role in the production of ejection murmurs. Circ Res (1976) 1.27
Real-time analysis of the transcriptional regulation of HIV and hCMV promoters in single mammalian cells. J Cell Sci (1995) 1.27
Multiple gated cardiac blood pool imaging for left ventricular ejection fraction: validation of the technique and assessment of variability. Am J Cardiol (1979) 1.26
Evaluation of VP22 spread in tissue culture. J Virol (2000) 1.25
Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. N Engl J Med (1979) 1.25
Turbulent blood flow in the ascending aorta of humans with normal and diseased aortic valves. Circ Res (1976) 1.25
Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med (1992) 1.24
Sleep-induced periodic breathing and apnea: a theoretical study. J Appl Physiol (1985) (1991) 1.24
The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis. Ann Intern Med (1998) 1.23
An alternative method for determination of the carpal height ratio. J Bone Joint Surg Am (1994) 1.22
Exercise training in patients with heart failure. A randomized, controlled trial. Ann Intern Med (1996) 1.22
Venous thromboembolism in neurosurgery and neurology patients: a review. Neurosurgery (1994) 1.22
A new noninvasive management strategy for patients with suspected pulmonary embolism. Arch Intern Med (1989) 1.21
Assessment of cardiac performance with quantitative radionuclide angiocardiography: sequential left ventricular ejection fraction, normalized left ventricular ejection rate, and regional wall motion. Circulation (1977) 1.20
Perfusion scan in pulmonary vascular/lymphangitic carcinomatosis: the segmental contour pattern. AJR Am J Roentgenol (1981) 1.19
Selection and interpretation of clinical pathology indicators of hepatic injury in preclinical studies. Vet Clin Pathol (2005) 1.17
Hemodynamic determinants of the frequency and amplitude of a musical murmur produced by a regurgitant mitral bioprosthetic valve. Am J Cardiol (1982) 1.16